Literature DB >> 15980695

The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa.

Gita Ramjee1, Brian Williams, Eleanor Gouws, Eddy Van Dyck, Bénédicte De Deken, Salim Abdool Karim.   

Abstract

This study investigated the impact of prevalent and incident HSV-2 infection on the incidence of HIV-1 infection in a cohort of female commercial sex workers in KwaZulu-Natal, South Africa. Prior to a vaginal microbicide trial, 416 women were screened for antibodies to HIV-1 and herpes simplex virus-2 (HSV-2) infections and a questionnaire was used to establish behavioral, social, and demographic characteristics. A total of 187 HIV-1-seronegative women were followed up at monthly intervals when blood was drawn and used to detect HIV-1 and HSV-2 antibodies. The median duration of follow-up was 2.2 years. At screening 50% of the women were HIV-1 seropositive and 84% were HSV-2 seropositive. The hazards of HIV-1 among women who were HSV-2 seropositive or seronegative throughout, or among those who seroconverted during the study, were not significantly different. When HSV-2 seroconversion was analyzed as a time-dependent covariate, the hazard ratio for HIV-1 seroconversion was 6.0 (95% CI: 2.6-14.0) times greater among women with incident than among women with prevalent HSV-2 infections. Drawing on other recent studies these data suggest that incident HSV-2 infection increases the risk of HIV-1 infection; the effect wanes with time since infection; and the effect is significantly greater for men than it is for women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15980695     DOI: 10.1097/01.qai.0000144445.44518.ea

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  33 in total

1.  Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

Authors:  Glenda E Gray; Mary Allen; Zoe Moodie; Gavin Churchyard; Linda-Gail Bekker; Maphoshane Nchabeleng; Koleka Mlisana; Barbara Metch; Guy de Bruyn; Mary H Latka; Surita Roux; Matsontso Mathebula; Nivashnee Naicker; Constance Ducar; Donald K Carter; Adrien Puren; Niles Eaton; M Julie McElrath; Michael Robertson; Lawrence Corey; James G Kublin
Journal:  Lancet Infect Dis       Date:  2011-05-11       Impact factor: 25.071

2.  Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa.

Authors:  Koleka Mlisana; Nivashnee Naicker; Lise Werner; Lindi Roberts; Francois van Loggerenberg; Cheryl Baxter; Jo-Ann S Passmore; Anneke C Grobler; A Willem Sturm; Carolyn Williamson; Katharina Ronacher; Gerhard Walzl; Salim S Abdool Karim
Journal:  J Infect Dis       Date:  2012-04-19       Impact factor: 5.226

Review 3.  Herpes simplex virus type 2: epidemiology and management options in developing countries.

Authors:  G Paz-Bailey; M Ramaswamy; S J Hawkes; A M Geretti
Journal:  Sex Transm Infect       Date:  2006-11-10       Impact factor: 3.519

4.  Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.

Authors:  Sinéad Delany-Moretlwe; Ute Jentsch; Helen Weiss; Jocelyn Moyes; Rhoda Ashley-Morrow; Wendy Stevens; Philippe Mayaud
Journal:  Sex Transm Infect       Date:  2009-10-16       Impact factor: 3.519

5.  Herpes simplex virus-2 infection in male rural migrants in Shanghai, China.

Authors:  N He; H Cao; Y Yin; M Gao; T Zhang; R Detels
Journal:  Int J STD AIDS       Date:  2009-02       Impact factor: 1.359

6.  A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in Kenya.

Authors:  V Chohan; J M Baeten; S Benki; S M Graham; L Lavreys; K Mandaliya; J O Ndinya-Achola; W Jaoko; J Overbaugh; R S McClelland
Journal:  Sex Transm Infect       Date:  2009-05-19       Impact factor: 3.519

7.  The Effect of Commonly Used Excipients on the Epithelial Integrity of Human Cervicovaginal Tissue.

Authors:  Minlu Hu; Tian Zhou; Charlene S Dezzutti; Lisa C Rohan
Journal:  AIDS Res Hum Retroviruses       Date:  2016 Oct/Nov       Impact factor: 2.205

8.  Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa.

Authors:  Joelle Sobngwi-Tambekou; Dirk Taljaard; Pascale Lissouba; Kevin Zarca; Adrian Puren; Emmanuel Lagarde; Bertram Auvert
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

9.  Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa.

Authors:  Gita Ramjee; Handan Wand
Journal:  Bull World Health Organ       Date:  2012-07-16       Impact factor: 9.408

10.  Building protective factors to offset sexually risky behaviors among black youths: a randomized control trial.

Authors:  Carl C Bell; Arvin Bhana; Inge Petersen; Mary M McKay; Robert Gibbons; William Bannon; Anup Amatya
Journal:  J Natl Med Assoc       Date:  2008-08       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.